Cargando…

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies

Chronic lymphocytic leukaemia (CLL) is a malignancy of clonally expanded antigen-switched, neoplastic, mature B cells. CLL is characterised by a variable degree of immunosuppression and secondary hypogammaglobulinemia. B-cell depleting therapies have historically been deployed with a proportion of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Sujoy, Allsup, David, Molica, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117948/ https://www.ncbi.nlm.nih.gov/pubmed/37091176 http://dx.doi.org/10.3389/fonc.2023.1135812

Ejemplares similares

Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
por: Ferrer, Gerardo
Publicado: (2018)

Immunoglobulin heavy variable somatic hyper mutation status in chronic lymphocytic leukaemia: on the threshold of a new era?
por: Langerak, Anton W., et al.
Publicado: (2020)

Will New Drugs Replace Transplants for Chronic Lymphocytic Leukaemia?
por: Yang, Shenmiao, et al.
Publicado: (2021)

Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia
por: René, Céline, et al.
Publicado: (2014)

Abnormal Chromatin Clumping in Myeloblasts Mimicking Chronic Lymphocytic Leukaemia: A Diagnostic Pitfall
por: Sehgal, Tushar, et al.
Publicado: (2021)

NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia
por: Edelmann, Jennifer
Publicado: (2022)

Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy
por: Woo, Timothy, et al.
Publicado: (2023)

Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome
por: Till, Kathleen J., et al.
Publicado: (2017)

Perspectives on the Application of Cytogenomic Approaches in Chronic Lymphocytic Leukaemia
por: Wan Mohamad Zamri, Wan Norizzati, et al.
Publicado: (2023)

The Evolution of Therapies Targeting Bruton Tyrosine Kinase for the Treatment of Chronic Lymphocytic Leukaemia: Future Perspectives
por: Eyre, Toby A., et al.
Publicado: (2023)

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
por: Kolijn, P. Martijn, et al.
Publicado: (2021)

Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
por: Molica, Stefano
Publicado: (2020)

TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia
por: Puzzolo, Maria Cristina, et al.
Publicado: (2021)

Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era
por: Xu, Zheng-Li, et al.
Publicado: (2020)

Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option
por: Molica, Stefano, et al.
Publicado: (2023)

Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia
por: Molica, S, et al.
Publicado: (2002)

Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia
por: Molica, Stefano, et al.
Publicado: (2011)

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia
por: Molica, Matteo, et al.
Publicado: (2019)

Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing
por: Davi, Frédéric, et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia
por: Naylor-Adamson, Leigh, et al.
Publicado: (2021)

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
por: Takács, Ferenc, et al.
Publicado: (2022)

Ibrutinib continues to influence the therapeutic landscape of chronic lymphocytic leukemia: new data presented at ASCO 2017
por: Molica, Stefano
Publicado: (2017)

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.
por: Hamblin, T. J., et al.
Publicado: (1980)

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

Response to ibrutinib in chronic lymphocytic leukemia improves in quality with time
por: Molica, Stefano, et al.
Publicado: (2016)

Chronic lymphocytic leukemia paradigm continues to be refined: news from the American Society of Hematology 2018 annual meeting
por: Molica, Stefano
Publicado: (2019)

P603: INFECTIONS BEFORE AND DURING IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
por: Brieghel, Christian, et al.
Publicado: (2023)

Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia
por: Wu, Sheng-Cheng, et al.
Publicado: (2023)

Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
por: Acik, Didar Yanardag, et al.
Publicado: (2019)

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations
por: Rosenquist, R, et al.
Publicado: (2017)

Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives
por: Hurtado-de-Mendoza, David, et al.
Publicado: (2017)

Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective
por: Kwok, Marwan, et al.
Publicado: (2021)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
por: Zarobkiewicz, Michał K., et al.
Publicado: (2022)

Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia
por: Mustafa, S. Shahzad, et al.
Publicado: (2021)

A case of leukaemia cutis in a dog with T‐cell chronic lymphocytic leukaemia
por: Bae, Hyeona, et al.
Publicado: (2022)

Ribosomal RNA Synthesis in Chronic Lymphocytic Leukaemia
por: Billington, R. W., et al.
Publicado: (1974)

NICE recommends acalabrutinib for chronic lymphocytic leukaemia
Publicado: (2021)

Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles
por: Deng, Xinyue, et al.
Publicado: (2023)

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents
por: Tadmor, Tamar, et al.
Publicado: (2021)

Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia
por: Yi, Xue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hmt2n4bungob0b6rsukl867i9e